StonvexLoading…
StonvexStonvexStonvexCore line items from LRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.88B | $1.25B | $620.88M | $2.41B |
Operating Income | $344.92M | $215.84M | $68.98M | $360.09M |
Net Income | $256.80M | $99.48M | $68.80M | $287.94M |
EPS (Diluted) | $5.39 | $3.49 | $1.40 | $5.95 |
Total Assets | $2.45B | $2.31B | $2.33B | $2.29B |
Total Liabilities | $805.01M | $758.71M | $805.71M | $814.34M |
Cash & Equivalents | $614.05M | $497.10M | $518.44M | $782.50M |
Free Cash Flow OCF − CapEx | $116.38M | $-104.00M | $-196.09M | $431.04M |
Shares Outstanding | 42.53M | 42.59M | 43.86M | 43.52M |